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Background: Deep brain stimulation of the subthalamic nucleus, although highly effective
for the treatment of motor impairment in Parkinson’s disease (PD), can induce speech
deterioration in a subgroup of patients. The aim of the current study was to survey (1) if
there are distinctive stimulation effects on the different parameters of voice and speech
and (2) if there is a special pattern of preexisting speech abnormalities indicating a risk for
further worsening under stimulation.
Methods: N =38 patients with PD had to perform a speech test without medication with
stimulation ON (StimON) and stimulation OFF (StimOFF). Speech samples were analyzed:
(1) according to a four-dimensional perceptual speech score and (2) by acoustic analysis to
obtain quantifiable measures of distinctive speech parameters.
Results: Quality of voice was ameliorated with StimON, and there were trends of increased
loudness and better pitch variability. N =8 patients featured a deterioration of speech with
StimON, caused by worsening of articulation or/and fluency. These patients already had
more severe overall speech impairment with characteristic features of articulatory slurring
and articulatory acceleration under StimOFF condition.
Conclusion: The influence of subthalamic StimON Parkinsonian speech differs consider-
ably between individual patients, however, there is a trend to amelioration of voice quality
and prosody. Patients with stimulation-associated speech deterioration featured higher
overall speech impairment and showed a distinctive pattern of articulatory abnormalities
at baseline. Further investigations to confirm these preliminary findings are necessary to
allow neurologists to pre-surgically estimate the individual risk of deterioration of speech
under stimulation.
Keywords: deep brain stimulation of the subthalamic nucleus, Parkinson’s disease, dysarthria, quality of voice,
speech impairment, perceptual analysis of speech, acoustic speech analysis
INTRODUCTION
Chronic deep brain stimulation of the subthalamic nucleus (STN-
DBS) has been shown to be superior over best medical treatment
in patients with motor fluctuations in Parkinson’s disease (PD)
(1, 2). However, the effects of STN-DBS on voice and speech
have been found to be variable or even adverse, at least in a
subgroup of patients. According to overall perceptual evaluation
based upon the speech item of the Unified Parkinson’s Disease Rat-
ing Scale/Motor Score (UPDRS III), the prevalence of dysarthria
under STN-DBS has been reported to vary between 1% after
6 months up to 70% at 3 years follow-up with an average of 9.3%
(3–5). Furthermore, “communication” was the only item of the
PD Questionnaire that showed deterioration under STN-DBS in
the recently published EARLYSTIM study (6). However, there
are also reports of an amelioration of distinctive parameters of
voice, loudness, and non-speech vocal measures in individual PD
patients under STN-DBS (7–13). As a possible explanation for
these contradictory findings, it has been proposed that STN-DBS
could reduce a few distinctive dysarthrophonic symptoms such as
reduced loudness and glottic tremor in PD. However, these ben-
eficial effects could be outweighed by a general dysarthrogenic
impact on prosodic and articulatory functions leading to reduced
overall speech intelligibility (7, 14–17). Furthermore, as a possi-
ble hint for a negative effect on basal motor speech performance,
STN-DBS was found to induce abnormalities in the speed and reg-
ularity of non-speech syllable repetition (18). In respect to these
conflicting results, there is still a lack of reliable predictability of
speech motor outcome in the individual patient, although clinical
and surgical factors (e.g., anatomic location of the electrode con-
tact, amplitude of current in the right and left STN) seem to be
critical for the speech outcome under STN-DBS (19).
The aim of the current study was to analyze the effect of STN-
DBS on voice and speech in a group of PD patients based upon
perceptual and acoustic analysis of distinctive speech modalities.
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It had been chosen to test patients without the additional effect
of dopaminergic medication to identify the exclusive impact of
STN-DBS with stimulation settings previously optimized for best
overall motor performance in order to test patients under their
“naturalistic” stimulation situation. According to previous stud-
ies, it had been hypothesized that there would be a differential
outcome of patients’ speech performance under stimulation and
therefore, it was further intended to better characterize the pat-
tern of changes within the single speech modalities. In particular,
attention was given to the expected subgroup of patients with a
deterioration of speech performance under stimulation in order
to identify patterns of preexisting speech impairment that might
serve as “risk profile” for further worsening under STN-DBS.
PATIENTS AND METHODS
From 2008 to 2010, 38 patients with idiopathic PD and chronic
bilateral STN-DBS were recruited for this study. The diagno-
sis of PD was based upon the UK Parkinson’s Disease Society
Brain Bank Criteria (20). After an overnight wash out period of
medication, each patient was tested under two conditions OFF
medication: stimulation OFF (StimOFF) and stimulation ON (Sti-
mON) and underwent a neurological examination according to
UPDRS Motor Scale (UPDRS III) immediately before perform-
ing the speech task. Patients’ characteristics are summarized in
Table 1.
As control group we tested 30 age-matched healthy persons.
All participants were native German speakers, and the speech
evaluation was based upon a German text. For the speech test, each
participant had to read a given text composed of four phonetically
balanced sentences; furthermore, participants had to produce the
vowel, /a/, for as long as possible. Speech samples were digitally
recorded using a commercial audio software (Steinberg Wave-
Lab®/Steinberg Media Technologies GmbH, Hamburg, Germany)
and a head-set microphone with a defined mouth to microphone
distance. Speech records of the reading task were perceptually ana-
lyzed independently by two examiners (Sabine Skodda and Wenke
Grönheit) who were blinded for the speakers’ condition, according
to a four-dimensional scoring system that is used for the descrip-
tion of Parkinsonian dysarthria in our clinic (Table 2). Inter-rater
reliability was high with w = 0.923; in cases of divergent ratings,
the higher score was chosen for the further analysis.
Additionally, acoustic analysis of speech was performed for sev-
eral speech parameters for the objective description of voice, artic-
ulation, fluency, and prosody by the use of PRAAT (21) (Table 3).
Jitter, shimmer, and noise to harmonics-ratio as measures of voice
quality were based upon the analysis of sustained phonation (22).
Mean fundamental frequency (meanF0) of the reading task was
taken as measure of phonation. Loudness was defined as average
sound pressure level of the entire reading task. Description of into-
nation variability was based upon standard deviation (SD) of the
fundamental frequency (F0SD). Analysis of speech rate was per-
formed by measuring the length of each syllable and each pause
respectively based on the oscillographic sound pressure signal.
Besides the conventional speech rate variables as net speech rate
(NSR) and pause ratio (PR%), we additionally defined the per-
cent ratio of pauses within polysyllabic words (Pinw%), which can
be taken as a measure of precision of stop consonant articulation
(23). Articulatory acceleration (AA) in the course of reading was
defined as the difference of NSR between the first and last sentence
with values >0 indicating acceleration (23). Description of vowel
Table 1 | Participants’ characteristics/results of the comparison of perceptual speech analysis.
Control group PD group
StimOFF/MedOFF StimON/MedOFF
Mean/SD/range Mean/SD/range Mean/SD/range
Age (y) 67.14/8.03/48–80 65.69/7.85/45–77
Age at DBS surgery 62.13/8.01/43–73
Disease duration (y) 15.71/6.07/6–28
Disease duration at DBS surgery 12.24/6.97/5–24
Median/1.–3. quartile Median/1.–3. quartile Median/1.–3. quartile
UPDRS III 39/32.75–47 21.37/10.17/7–50 p<0.0001
UPDRS III axial subscore (% of overall UPDRS score) 11/8.75–16 (29.50%) 7/5–10.25 (37.74%) p<0.0001
UPDRS III tremor subscore (% of overall UPDRS score) 3.5/0–8 (11.95%) 0/0–2.25 (6.47%) p<0.0001
UPDRS III akinesia subscore (% of overall UPDRS score) 25/19–29.50 (60.72%) 13/7–20.25 (61.90%) p<0.0001
UPDRS III speech item 1/0–2 1/0–2 n.s.
Perceptual speech score 1/0–2*** 5/4–7 5/3–7 n.s. (p=0.085)
Voice 0/0–1**** 1/1–2 1/1–1.25 p=0.001
Articulation 0/0–0**** 2/1–2 2/1–2 n.s
Fluency 0/0–0**** 1/1–2 1/1–2 n.s
Prosody 0/0–0**** 1/0–1.25 1/0–1 n.s.
***p<0.001.
****p<0.0001 related to the comparison between control group and PD group with StimOFF/MedOFF.
y, years; SD, standard deviation; n.s., not significant; UPDRS III, unified Parkinson’s disease rating scale, Part III: motor part.
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Table 2 | Perceptual speech score.
Speech modality Definition
Voice 0 Normal
1 Voice quality slightly hoarse, slightly reduced loudness, intermittently present
2 Voice quality hoarse or tremulous, slightly reduced loudness, continuously present
3 Voice quality hoarse or tremulous, markedly reduced loudness
4 Marked reduction of voice quality, whispery, or scratchy voice
Articulation 0 Normal articulation
1 Slightly reduced articulatory accuracy, intermittently present
2 Slightly reduced articulatory accuracy, continuously present
3 Markedly reduced articulatory accuracy, slightly reduced intelligibility
4 Markedly reduced intelligibility
Tempo/fluency 0 Normal speech tempo and distribution of speech pauses
1 Slightly reduced or accelerated speech tempo, intermittently present
2 Rushes of speech and prolonged pauses, not very pronounced or only intermittently present; or slightly reduced speech tempo
3 Rushes of speech and prolonged pauses, very pronounced or continuously present; or markedly reduced speech tempo
4 Palilalia
Prosody 0 Normal pitch variability
1 Slightly monotone
2 Extremely monotone
Table 3 | Abbreviations and definitions of the speech parameters.
Speech modality Parameter Definition
Voice Jitter (measure of
microperturbations of frequency)
Average absolute difference between consecutive differences between consecutive
periods, divided by the average period
Shimmer (measure of
microperturbations of amplitude)
Average absolute difference between consecutive differences between the amplitude of
consecutive periods
Noise to harmonics ratio (nhR) Automatic comparison of harmonic (periodically recurring) and inharmonic sound fractions
Loudness in dB Average sound pressure level calculated for entire reading task
MeanF0 Average fundamental frequency F0 calculated for entire reading task
Articulation Vowel articulation index (VAI) Comprehensive measure of the “working space” for vowels based upon the extraction of
formant frequencies of defined vowels of the reading task according to the formula
VAI= (F2/i/+F1/α/)/(F1/i/+F1/u/+F2/u/+F2/α/)
Percentage of pauses within
polysyllabic words (Pinw%)
Percentage of pauses within polysyllabic words of total speech pauses (periods of silence
<10 ms)
Tempo/fluency Net speech rate (NSR) Net production of syllables per second based upon reading task
Pause ratio (PR%) Percentage of pause rate based upon the reading task
Articulatory acceleration (AA) Difference between NSR of the first and last sentence of the reading task (values >0
display acceleration)
Prosody F0SD Standard deviation of fundamental frequencies calculated for the reading task as a
measure of pitch variability
articulation was based upon the recently established vowel articu-
lation index/VAI, which is a surrogate parameter of the first and
second formant frequencies (F1 and F2) of the three corner vowels,
/α/, /i/, and /u/ (24, 25). Since meanF0, F0SD, and VAI are related
to the speaker’s pitch of voice, the comparison of these parameters
between PD patients and controls were performed separately for
both genders.
Winstat© (Bad Krotzingen/Germany) was used for statisti-
cal analyses. ANOVA and paired t -test were performed for the
comparison of patients with the control group and intra-group
comparison (StimOFF vs. StimON). The variables were normally
distributed (Shapiro–Wilk test). Continuous variables are pre-
sented using mean±SD. Discrete data are reported with median
and quartile deviation. For the calculation of inter-rater reliability,
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Kendall’s coefficient of concordance was used. Spearman rank test
was used to perform correlation analyses in order to account for
possible outliers especially within the subgroup analyses. Due to
the exploratory nature of the study, no adjustments for multiple
comparisons were made, and the level of significance was set at
p< 0.05.
Our study was in compliance with the Helsinki Declaration
and had been approved by the local Ethics Committees. Written
informed consent was obtained from each participant.
RESULTS
COMPARISON OF CONTROL GROUP WITH PD GROUP StimOFF
Based upon perceptual ratings, the control group featured a sig-
nificantly better performance of voice, articulation, fluency, and
prosody. This was reflected in the acoustic analysis by lower values
for jitter, shimmer,and noise to harmonics-ratio indicating a better
voice quality, by higher sound pressure levels, higher values for the
measures of articulatory precision (Pinw%, VAI) and pitch vari-
ability (F0SD), and an elevated meanF0 in female speakers. Mea-
sures of speech rate and PR% showed no significant differences
between the control and the PD group in the StimOFF condition.
This pattern of speech abnormalities was in general preserved
also under StimON: there were significantly worse values for shim-
mer, loudness, VAI, Pinw%, and F0SD, whereas no significant
differences compared to the control group were seen concerning
shimmer, meanF0, NSR, PR%, and AA (numerical data are given
in Tables 1 and 4).
CORRELATIONS BETWEEN PERCEPTUAL AND ACOUSTIC ANALYSIS
In the PD group in the OFF condition, there were found
some significant correlations between “voice” and the jitter
(r = 0.343, p= 0.019) and shimmer values (r = 0.289, p= 0.041),
between “articulation” and Pinw% (r =−0.277, p= 0.046),
but not with VAI, between “fluency” and NSR (r = 0.385,
p= 0.008) and AA (r = 0.478, p= 0.001), but not with PR%,
and between “prosody” and F0SD (r =−0.311, p= 0.028). In
general, similar correlations between perceptual and acoustic
measures were also observed in the ON condition (data not
shown).
In the control group, no close correlations were expected
because of the low overall speech impairment with an average
perceptual sum speech score of 0.88. Accordingly, there were
only weak correlations between the perceptual categories “voice,”
“articulation,” “fluency,” and “prosody” on the one hand, and the
accordant acoustic measures on the other (“voice”/jitter: r = 0.417,
p= 0.021; no significant correlations with shimmer, nhR, and
loudness; “articulation”/VAI: r = 0.307, p= 0.072, no correlation
with Pinw%; “fluency”/PR%: r = 0323, p= 0.062, “fluency”/AA:
r = 0.339, p= 0.052, no correlation with NSR; “prosody”/F0SD:
r =−0.388, p= 0.031).
COMPARISONWITHIN THE PD GROUP: StimOFF VS. StimON:
GROUPWISE COMPARISONS
Total UPDRS III scores as well as the chosen UPDRS subscores
(axial, tremor, akinesia) were significantly ameliorated under Sti-
mON condition, whereas UPDRS speech score (item 18) showed
no significant difference. The more detailed perceptual speech
score showed a tendency to reduced overall ratings that were
mainly caused by an amelioration of voice quality in the StimON
condition whereas the other speech modalities remained widely
unchanged. Similar results were observed with the measures of the
acoustic analysis where only sound pressure levels and meanF0 in
Table 4 | Comparison between the PD groups with stimulation OFF and ON and comparison between the PD group/StimOFF and the control
group.
Control (n=30, 15 male) PD patients (n=38, 22 male) Comparison StimOFF/Med OFF vs.
StimON/MedOFF
StimOFF/MedOFF StimON/MedOFF
Mean/SD Mean/SD Mean/SD
Jitter 1.247/0.704** 2.065/1.941 1.857/2.040 n.s
Shimmer 5.613/2.722*** 10.733/7.246 9.272/5.980 n.s.
nhR 0.038/0.033** 0.086/0.097 0.078/0.089 n.s.
Loudness (dB) 78.92/2.10**** 70.02/7.54 71.02/8.10 n.s. (p=0.064)
MeanF0 male 118.46/13.98 117.96/19.40 121.67/18.39 n.s.
MeanF0 female 192.83/8.51* 169.28/42.59 191.01/23.47 n.s. (p=0.05)
VAI male 0.781/0.070**** 0.668/0.074 0.657/0.058 n.s.
VAI female 0.914/0.050**** 0.721/0.060 0.714/0.069 n.s.
Pinw% 29.77/8.53**** 15.53/10.66 14.85/10.90 n.s.
NSR 5.23/0.56 5.30/1.06 5.23/1.13 n.s.
PR% 18.61/4.17 17.29/9.06 18.31/9.53 n.s.
AA 0.22/0.34 0.35/0.57 0.35/0.57 n.s.
F0SD male 20.13/6.78** 14.58/4.29 15.42/4.45 n.s.
F0SD female 31.86/6.11**** 16.76/5.31 19.69/4.90 n.s.
*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
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female PD speakers showed a (non-significant) tendency to ame-
lioration. However, no further changes were observed between
StimOFF and StimON conditions in the groupwise comparison
(numerical data are given in Tables 1 and 4).
COMPARISONS WITHIN THE PD GROUP AND CHARACTERIZATION OF
THE SUBGROUP WITH SPEECH DETERIORATION
In an evaluation of the different qualitative speech modalities in
the individual patients, 12/38 patients showed no difference in the
sum perceptual speech score, 18/38 showed an amelioration of
the sum speech score (13 patients improved by 1 point, 4 patients
by 2 points, and 1 patient by 3 points respectively), which was
mainly caused by an improvement of voice (n= 12) and less often
by amelioration of articulation (n= 7), prosody (n= 4), or flu-
ency (n= 1). These improvements showed no correlation with
improvement of motor symptoms as tremor, akinesia, or axial
symptoms based upon the accordant UPDRS III subscores.
In 8/38 patients, there was a deterioration of speech (6 patients
worsened by 1 point, 1 patient each worsened by 2 points and 3
points respectively) with worsening of articulation in 4 patients, of
fluency in 3, of prosody in 3, and of voice in 1 patient. The group
of patients with speech deterioration showed no significant differ-
ence concerning age and disease duration, however, UPDRS III was
significantly higher in StimOFF. No differences were seen with the
tremor, akinesia, or axial UPDRS subscores. The UPDRS speech
item showed a tendency to higher values, however, without statisti-
cal significance. In 5/8 patients with speech deterioration, the right
STN was stimulated with higher current amplitudes (compared to
11/30 in the subgroup without worsening of speech) than the left-
side STN due to asymmetry of motor symptoms going along with
higher total electric energy delivered/TEED (26) since pulse width,
frequency, and impedances (measured in n= 30 patients) showed
no significant differences (see Table 5).
Regarding the perceptual rating of speech performance in Sti-
mOFF, no significant differences were seen concerning voice, artic-
ulation, and prosody, but there was a tendency to higher impair-
ment in the“fluency”category and the sum perceptual score as well
(see Table 6). Based upon acoustic analysis, the speech pattern in
the OFF condition in the subgroup with speech worsening under
stimulation was characterized by significant reduction of Pinw%
and higher grade of articulatory acceleration/AA. The other mea-
sures of speech rate (NSR and PR%) at least showed a tendency
to higher average articulatory velocity/NSR and elevated ratio of
speech pauses/PR%. No significant differences were found with the
remaining measures of speech (see Table 6). Furthermore, higher
UPDRS III scores in the OFF condition were correlated to more
pronounced worsening of articulation (r =−0.655, p= 0.039)
and overall speech performance (r =−0.608, p= 0.055) accord-
ing to the perceptual speech score. Similarly, higher measures of
AA showed a correlation to articulatory worsening (r = 0.655,
p= 0.039) and higher values for jitter, shimmer, and nhR were cor-
related with an elevation of the perceptual sum speech score under
stimulation (r = 0.733–0.764, p= 0.014–0.019 respectively). No
such “OFF condition” pattern or similar correlations could be
identified for the subgroup of patients who featured no speech
worsening under stimulation.
DISCUSSION
In the groupwise comparison of speech in the StimOFF and ON
conditions, only perceptual assessment of voice quality showed
a significant amelioration under STN-DBS, which was mirrored
by similar trends toward lower values for the accordant acoustic
measures (jitter, shimmer, and nhR) as well as higher values for
loudness of speech in the acoustic analysis, however, without
statistical significance. These findings are in line with previous
investigations reporting on a stimulation-induced improvement
of voice quality and loudness, however, not necessarily accompa-
nied by an amelioration of overall speech performance (6–12) that
can in general be confirmed by our data. In the current study, per-
ceptual and acoustic measures of articulation,fluency,and prosody
showed no consistent behavior under STN-DBS, instead, there was
a group of n= 8 patients with worsening of overall speech perfor-
mance that could not be restricted to a consistent pattern but
was induced by different degrees of deterioration of articulation,
fluency, and prosody.
One main result of the present investigation was the identifica-
tion of a subgroup with preexisting speech abnormality in the OFF
condition that showed a further deterioration under stimulation.
The preexisting pattern of dysarthria was found to be characterized
by a high degree of articulatory slurring (as mirrored by reduced
Pinw%) accompanied by an acceleration of speech in the course of
the performance (indicated by significantly elevated AA). Further-
more, these patients featured not only higher overall UPDRS III
scores in the OFF condition, but worse global speech performance
(according to UPDRS speech item and the perceptual sum score) as
well, however without statistical significance which might be due
to the small sample size of n= 8. In this subgroup of patients with
speech deterioration, there also was a correlation between higher
values for UPDRS III, articulatory acceleration/AA and poor voice
quality (indicated by higher values for jitter, shimmer, and nhR) in
the OFF condition and the perceptually detected degree of speech
worsening under stimulation.
There are only very few previous studies focused on the pre-
existing patients’ characteristics which might be “risk factors” for
stimulation-induced speech deterioration. Dromey and Bjarnason
tested six PD patients with speech deterioration under STN-DBS
according to perceptual ratings, however, acoustic measures of
articulation and phonation deriving from analysis of speech and
non-speech utterances showed mixed results with some speakers
improving and others becoming worse on individual measures
(27). In another investigation, negative effects on speech intel-
ligibility were found in two out of seven PD patients and were
attributed to slight stimulation-induced facial dyskinesia, which
was not observed in our study (28). Pützer and coworkers obtained
objective measures of phonatory and articulatory movements
based upon acoustic analysis of non-speech syllable production
in nine PD patients and reported mixed results under stimula-
tion: Precision of glottal and supraglottal articulation as well as
the phonatory function was reduced in some speakers, whereas
for others an improvement was observed (15). In a subgroup of
patients, the accuracy of stop consonant articulation was found to
be impaired under stimulation, which shows some relation to our
finding of increased Pinw% as a measure of overall articulatory
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slurring. However, in this previous study, the mixed response of
patients’ articulatory capacity had not been related to the speech
performance in the StimOFF condition.
Although the present study gives some first indication for spe-
cific patient-related risk factors for speech worsening under STN-
DBS, there are some undisputable limitations, especially because
of the small sample size, which lessens the value of the statistic
analysis. Since there was an overlap of values for AA and Pinw%
in the “deteriorating” group and the group of patients with no
stimulation-induced worsening of speech, positive and negative
predictive values for these measures were only poor. Besides, it
has to be mentioned that the speech evaluation was based upon
a German text and therefore, some of the findings could be
language-dependent.
Furthermore, the impact of surgical factors has not been
accounted for although in previous studies, the position of the
stimulation electrode within the medial and/or posterior portion
of the STN was linked with poorer speech intelligibility (19, 29,
30). However, even with electrodes exactly located within the STN,
a subgroup of 36% patients was found to feature a deterioration of
speech under stimulation in another study (31). This might at least
be explained by the explicit stimulation settings in the individual
patient since high amplitude and/or high frequency stimulation
was consistently found to be a risk factor for worsening of speech
(19, 29–34). Furthermore, selective or predominant stimulation
of the left-side STN was reported to induce profoundly negative
effects on prosody, articulation, and hence, intelligibility (33, 34).
In contrast, in our study, the majority of patients with speech
deterioration had higher stimulation amplitudes on the right-side
STN, and no clear differences were seen concerning frequencies,
pulse width and/or the electrode contacts chosen for stimulation.
These preliminary observations seem to underline the assump-
tion that surgical or stimulation factors alone cannot account for
overall speech performance under STN-DBS.
Another methodical weakness of our investigation is the lack
of pre-surgical speech data that would be necessary to rule out
a possible microlesion effect of electrode placement. Up till now,
there are only very few investigations with speech testings before
and at certain follow-up intervals after DBS surgery (11, 19, 28,
35). In the largest of these studies, there was a correlation between
poorer speech outcome after 1 year and higher pre-surgical general
motor impairment (19). Another study on seven patients found
no consistent effects of DBS surgery alone (that is, no hint of the
microlesion effect) and no consistent stimulation effect on speech
under STN-DBS after 3 months, but a slight improvement of pitch
variability and sound pressure levels under stimulation 6 months
post-op (27).
Summarized, despite some methodical limitations, the current
study provides first evidence for a specific patient-related“risk pro-
file,” namely high overall motor and speech impairment according
to UPDRS III and preexisting articulatory slurring and articula-
tory hastening, which seems to be associated with further decline
of speech performance under STN-DBS with stimulation settings
optimized for motor function. In this subgroup of patients, a pos-
itive effect of STN-DBS on phonatory and voice parameters seems
to be outweighed by a pro-dysarthrogenic stimulation effect that is
correlated to the degree of AA and overall voice impairment in the
OFF condition. Subsequent studies are warranted, especially with
pre-surgical speech recordings, to further corroborate these pre-
liminary findings to allow neurologists to pre-surgically estimate
the individual risk of deterioration of speech under STN-DBS.
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